ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
67,904.27
0.26%
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs Yen
157.2625
0.00%
Brent Oil
81.295
0.00%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. iTeos Therapeutics Inc (ITOS)

  7. iTeos Therapeutics Inc (ITOS) ニュース

ITOS

iTeos Therapeutics (ITOS)

iTeos Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ITOS
日付受信時刻ニュースソース見出しコード企業名
2024/05/1320 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ITOSiTeos Therapeutics Inc
2024/05/1105 : 35Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ITOSiTeos Therapeutics Inc
2024/05/1021 : 31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ITOSiTeos Therapeutics Inc
2024/05/1021 : 26GlobeNewswire Inc.iTeos Reports First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:ITOSiTeos Therapeutics Inc
2024/05/1021 : 24GlobeNewswire Inc.iTeos Therapeutics Announces $120 Million Registered Direct OfferingNASDAQ:ITOSiTeos Therapeutics Inc
2024/04/0805 : 30GlobeNewswire Inc.iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024NASDAQ:ITOSiTeos Therapeutics Inc
2024/03/0910 : 01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
2024/03/0910 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
2024/03/0909 : 58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
2024/03/0909 : 57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
2024/03/0810 : 01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
2024/03/0810 : 00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
2024/03/0621 : 19Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ITOSiTeos Therapeutics Inc
2024/03/0621 : 09Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ITOSiTeos Therapeutics Inc
2024/03/0621 : 01GlobeNewswire Inc.iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of DirectorsNASDAQ:ITOSiTeos Therapeutics Inc
2024/03/0621 : 00GlobeNewswire Inc.iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdatesNASDAQ:ITOSiTeos Therapeutics Inc
2024/03/0606 : 30GlobeNewswire Inc.iTeos to Highlight Preclinical Data on First-In-Class EOS-984 Targeting ENT1 at the American Association for Cancer Research Annual Meeting 2024NASDAQ:ITOSiTeos Therapeutics Inc
2024/03/0121 : 00GlobeNewswire Inc.iTeos to Participate in Upcoming Investor ConferencesNASDAQ:ITOSiTeos Therapeutics Inc
2024/01/1107 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ITOSiTeos Therapeutics Inc
2024/01/0821 : 00GlobeNewswire Inc.iTeos Announces 2024 Strategic Priorities and Anticipated MilestonesNASDAQ:ITOSiTeos Therapeutics Inc
2024/01/0321 : 00GlobeNewswire Inc.iTeos to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ITOSiTeos Therapeutics Inc
2023/12/0810 : 22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
2023/12/0810 : 22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
2023/12/0810 : 21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
2023/12/0810 : 20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
2023/12/0810 : 17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
2023/12/0810 : 16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
2023/12/0806 : 11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ITOSiTeos Therapeutics Inc
2023/11/2121 : 00GlobeNewswire Inc.iTeos to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:ITOSiTeos Therapeutics Inc
2023/11/0721 : 06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ITOSiTeos Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ITOS

最近閲覧した銘柄

COIN
VEGAAETH
Vega
NYSE
GS
Goldman Sachs
BIT
P1V7Y1
NLBNPIT1V7Y1 20991231 16...
EU
BQPEJ
Postal Bnk 0.00% 15/11/28
DBI
I1CL
IN XT SP500 EUR HEDGED EO
POLO
WOJAKUSDT
Wojak Coin
TG
PUM
Puma
BIT
I09823
IT0005574493 20240603 24.5
TSX
149A
Thinca
BIT
P20GV4
NLBNPIT20GV4 20240621 26
USOTC
BMBN
Benchmark Bankshares (PK)
BIT
P1YLY8
NLBNPIT1YLY8 20240621 280
BOV
PETRG371
PETRG371 Ex:34,37
EU
ACAPB
Credit Agricole SA 0.394...
BOV
ALUP4F
ALUPAR PN
BIT
P1ZUA6
NLBNPIT1ZUA6 20240621 40...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有